Anika Therapeutics ANIK
NASDAQ ANIK
$13.93 +0.46 (+3.41%)
As of: Nov 11, 2026 · 12:23 PM EST

Anika Therapeutics (ANIK) Net Equity Issued and Repurchased (2010 - 2026)

Updated

Anika Therapeutics' Net Equity Issued and Repurchased came in at $239,000 for Q4 2025, down 19.5% from $297,000 a year earlier.

Analysis

Anika Therapeutics (ANIK) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends

For FY2025, Anika Therapeutics' Net Equity Issued and Repurchased was $500,000, down 29.4% from FY2024.

  • Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -20.0% (FY2020 to FY2025).
  • Going back by year, Net Equity Issued and Repurchased was $708,000 in FY2024 (-12.0%), $805,000 in FY2023 (+21.1%), $665,000 in FY2022 (-41.0%) and $1.13 million in FY2021 (-26.0%).
  • The Q4 2025 figure represents the lowest quarterly Net Equity Issued and Repurchased since Q1 2024.
  • Year-over-year, Net Equity Issued and Repurchased increased in 1 of the last five quarters, with growth averaging 29.6%.
  • The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q4 2022 (growth of 470.2%), and the weakest in Q4 2021 (a decline of 92.2%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn -
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn 89.00 Mn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn 35.00 Mn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn -2.88 Bn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn -247.00 Mn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn -
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn 95.00 Mn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn -102.40 Mn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 8.00 Mn
10 Anika Therapeutics 180.43 Mn -104.21 Mn 18.84 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -853,000.00
Mar 31, 2026 -8.69 Mn
Dec 31, 2025 -5.28 Mn
Jun 30, 2025 261,000.00
Mar 31, 2025 -3.97 Mn
Dec 31, 2024 -5.28 Mn
Sep 30, 2024 -3.97 Mn
Jun 30, 2024 -906,000.00
Mar 31, 2024 23,000.00
Dec 31, 2023 335,000.00
Jun 30, 2023 486,000.00
Mar 31, 2023 7,000.00
Dec 31, 2022 666,000.00
Mar 31, 2022 15,000.00
Dec 31, 2021 114,000.00
Sep 30, 2021 371,000.00
Jun 30, 2021 643,000.00
Dec 31, 2020 1.46 Mn
Dec 31, 2019 326,000.00
Sep 30, 2019 21.82 Mn
API Access

Anika Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ANIK&period=max&api_key=YOUR_API_KEY